Amendments to Sublicense Agreement. a) For the avoidance of doubt, none of the following amendments to the Sublicense Agreement are intended to cause a breach of the Upstream Agreement and any amendment that would otherwise cause such a breach shall be null and void ab initio. b) Section 1 of the Sublicense Agreement is hereby amended to include the following:
Appears in 5 contracts
Samples: Sublicense Agreement (Ligand Pharmaceuticals Inc), Sublicense Agreement (Ligand Pharmaceuticals Inc), Sublicense Agreement (Retrophin, Inc.)
